154 related articles for article (PubMed ID: 7985543)
1. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
Baker TS; Bose CC; Caskey-Finney HM; King DJ; Lawson AD; Lyons A; Mountain A; Owens RJ; Rolfe MR; Sehdev M
Adv Exp Med Biol; 1994; 353():61-82. PubMed ID: 7985543
[TBL] [Abstract][Full Text] [Related]
2. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
[No Abstract] [Full Text] [Related]
3. Peptide epitopes in breast cancer mucins.
Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
[No Abstract] [Full Text] [Related]
4. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
Denton G; Sekowski M; Price MR
Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
[TBL] [Abstract][Full Text] [Related]
6. Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.
Mazor Y; Keydar I; Benhar I
Mol Immunol; 2005 Jan; 42(1):55-69. PubMed ID: 15488944
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of MUC1 peptides and fusion protein.
Apostolopoulos V; Pietersz GA; Xing PX; Lees CJ; Michael M; Bishop J; McKenzie IF
Cancer Lett; 1995 Mar; 90(1):21-6. PubMed ID: 7720038
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor-associated antigens in the biology and immunotherapy of breast cancer.
Taylor-Papadimitriou J; D'Souza B; Burchell J; Kyprianou N; Berdichevsky F
Ann N Y Acad Sci; 1993 Nov; 698():31-47. PubMed ID: 8279769
[No Abstract] [Full Text] [Related]
9. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
10. Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies.
Dion AS; Smorodinsky NI; Williams CJ; Wreschner DH; Major PP; Keydar I
Hybridoma; 1991 Oct; 10(5):595-610. PubMed ID: 1804772
[TBL] [Abstract][Full Text] [Related]
11. Recombinant breast carcinoma-associated mucins expressed in a baculovirus system contain a tumor specific epitope.
Hu P; Wright SE
Immunotechnology; 1998 Oct; 4(2):97-105. PubMed ID: 9853951
[TBL] [Abstract][Full Text] [Related]
12. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells.
Nuti M; Turchi V; Rughetti A; Viacava P; Masci AM; Castagna M; Frati L
Int J Biol Markers; 1992; 7(2):71-9. PubMed ID: 1378874
[TBL] [Abstract][Full Text] [Related]
14. A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts.
Hamann PR; Hinman LM; Beyer CF; Lindh D; Upeslacis J; Shochat D; Mountain A
Bioconjug Chem; 2005; 16(2):354-60. PubMed ID: 15769089
[TBL] [Abstract][Full Text] [Related]
15. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
Bashford JL; Robins RA; Price MR
Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies.
Xing PX; Prenzoska J; McKenzie IF
Mol Immunol; 1992 May; 29(5):641-50. PubMed ID: 1374842
[TBL] [Abstract][Full Text] [Related]
17. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
18. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
[TBL] [Abstract][Full Text] [Related]
19. Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.
Xing PX; Reynolds K; Pietersz GA; McKenzie IF
Immunology; 1991 Feb; 72(2):304-11. PubMed ID: 1707852
[TBL] [Abstract][Full Text] [Related]
20. Antigens for the selection of pan-variable number of tandem repeats motif-specific human antibodies against Mucin-1.
Persson J; Ohlin M
J Immunol Methods; 2006 Oct; 316(1-2):116-24. PubMed ID: 17022996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]